網頁Stemline Therapeutics, Inc. ist ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entdeckung, den Erwerb, die Entwicklung und die Vermarktung von onkologischen Therapeutika konzentriert. Das Unternehmen entwickelt etwa drei Produktkandidaten im klinischen Stadium, darunter SL-401, SL-701 und SL-801. 網頁2024年4月27日 · Stemline Therapeutics Switzerland GmbH is active according to the commercial register. The company with the UID number CHE-166.416.225 was founded …
Results of an open-label phase 1b study of the ERK inhibitor MK …
網頁Nov 2013 - Mar 20162 years 5 months. Munich Area, Germany. Business unit head, directly responsible and accountable for c.30M€ business, leadership of a cross-functional team including more than 90 people, as well as lead for the implementation of organisational redesign in the preparation of the Lixiana (edoxaban) launch. Reporting to DACH GM. 網頁Stemline Investor Relations Peter McDonald Stemline Therapeutics, Inc. 646-502-2307 Email: [email protected] Media Relations Andy Brimmer / Scott Bisang Joele Frank, Wilkinson Brimmer Katcher 212-355-4449 (Traduzione: in caso di conflitto vale handshake illinois login
Stemline Therapeutics LinkedIn
網頁Ob Praktikum, Direkteinstieg oder Berufserfahrene – unser Karriereportal bietet unterschiedliche Einstiegsmöglichkeiten. Hier geht’s zu Ihrer Bewerbung:… 網頁Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with … 網頁Company Overview. Stemline Therapeutics, a part of the Menarini Group, is focused on the development and commercialization of novel oncology therapeutics. The goal of our … handshake image png